You are here

SARC001

Completed
Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
Type of Sarcoma: 
Ewing's Family (including PNET), OsteosarcomaSynovial Sarcoma, Leiomyosarcoma, Rhabdomyosarcoma (including alveolar, embryonal and pleomorphic), Liposarcoma (all variants), Malignant Fibrous Histiocytoma, Peripheral Nerve Sheath (including MPNST, neurofibrosarcoma, schwannoma), Fibrosarcoma, Angiosarcoma (all variants), Desmoid Tumor, GI Stromal (c-kit negative only)
Drug: 
Imatinib Mesylate (Gleevec)
Accrual Status: 
Completed
Overall Study Principal Investigator: 
Laurence H. Baker, DO
University of Michigan

For more information about this trial and open sites: